Materials · Specialty Chemicals
Albemarle: revenue, profit and dividends
In fiscal 2025, Albemarle had revenue of $5.14B, up 6.2% a year on average since 2015, and a net loss of $511M. Its dividend per share has gone up 17 years in a row, to $1.62. It has 5% more shares than in 2015.
Revenue, fiscal 2025
average annual revenue growth since 2015 · −4.4% vs 2024
- Ticker
- ALB · NYSE
- Sector
- Materials
- Sub-industry
- Specialty Chemicals
- Headquarters
- Charlotte, North Carolina
- Founded
- 1994
- In the S&P 500 since
- July 1, 2016
- Latest fiscal year
- 2025, ended December 31, 2025
- SEC filer
- Albemarle Corp · CIK 0000915913
Revenue and net income
Revenue went from $2.47B in 2008 to $5.14B in 2025. Net loss in 2024–2025.
Diluted earnings per share
Diluted EPS went from $2.09 in 2008 to −$5.76 in 2025.
Dividends per share
Raised every year in the data: 17 years in a row, from 2009 to 2025. Ten-year growth: 3.4% a year.
Shares outstanding
5.5% more shares in 2025 than in 2015 (112M → 118M): new shares outweighed buybacks.
Operating cash flow, capex and free cash flow
Free cash flow (operating cash flow minus capital expenditure) was $692M in 2025, 13.5% of revenue. Negative in 2017–2021, 2023–2024.
The chart data could not be loaded. The table below has the same figures.
Year by year
| Fiscal year | Revenue | Net income | Net margin | Diluted EPS | Dividend | Shares | Operating cash flow | Capex | Free cash flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | $5.14B | −$511M | −9.9% | −$5.76 | $1.62 | 118M | $1.28B | $590M | $692M |
| 2024 | $5.38B | −$1.18B | −21.9% | −$11.20 | $1.61 | 118M | $688M | $1.68B | −$993M |
| 2023 | $9.62B | $1.57B | 16.4% | $13.36 | $1.60 | 118M | $1.33B | $2.15B | −$828M |
| 2022 | $7.32B | $2.69B | 36.7% | $22.84 | $1.58 | 118M | $1.91B | $1.26B | $646M |
| 2021 | $3.33B | $124M | 3.7% | $1.06 | $1.56 | 117M | $344M | $954M | −$609M |
| 2020 | $3.13B | $376M | 12.0% | $3.52 | $1.54 | 107M | $799M | $850M | −$51.6M |
| 2019 | $3.59B | $533M | 14.9% | $5.02 | $1.47 | 106M | $719M | $852M | −$132M |
| 2018 | $3.37B | $694M | 20.6% | $6.34 | $1.34 | 109M | $546M | $700M | −$154M |
| 2017 | $3.07B | $54.9M | 1.8% | $0.49 | $1.28 | 112M | $304M | $318M | −$13.7M |
| 2016 | $2.68B | $644M | 24.0% | $5.68 | $1.22 | 113M | $736M | $197M | $539M |
| 2015 | $2.83B | $335M | 11.8% | $3.00 | $1.16 | 112M | $361M | $228M | $133M |
| 2014 | $2.45B | $133M | 5.5% | $1.69 | $1.10 | 79.1M | $493M | $111M | $382M |
| 2013 | $2.39B | $413M | 17.3% | $4.90 | $0.96 | 84.3M | $433M | $155M | $278M |
| 2012 | $2.52B | $312M | 12.4% | $3.47 | $0.80 | 89.9M | $489M | $281M | $208M |
| 2011 | $2.87B | $392M | 13.7% | $4.28 | $0.67 | 91.5M | $487M | $191M | $297M |
| 2010 | $2.36B | $316M | 13.4% | $3.43 | $0.56 | 92.2M | $331M | $75.5M | $256M |
| 2009 | $2.01B | $178M | 8.9% | $1.94 | $0.50 | 92M | $359M | $101M | $258M |
| 2008 | $2.47B | $194M | 7.9% | $2.09 | $0.48 | 92.7M | $327M | $99.7M | $227M |
Fiscal years, labelled by the year in which they end. US dollars; per-share figures and share counts adjusted for splits. —: not in the data.
About these figures
- Older years are as filed at the time and may predate later restatements, mergers or spin-offs. How the figures are made.
Other Specialty Chemicals companies
Source: SEC EDGAR (company filings), data as of November 8, 2026. Sectors, sub-industries, headquarters and index dates: Wikipedia, CC BY-SA 4.0.